Status:
RECRUITING
Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Epilepsy Foundation
Conditions:
Progressive Myoclonus Epilepsy Type 1
EPM1
Eligibility:
All Genders
Brief Summary
The Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1) is focused on gathering longitudinal clinical data as well as biological samples (blood and/or urine) from male ...
Detailed Description
Progressive myoclonus-epilepsies (PME) are severe epilepsies that insinuate into the lives of previously healthy children or young adults, irrevocably intensify, and become intractable. Progressive My...
Eligibility Criteria
Inclusion
- Molecular diagnosis of EPM1-related disease
- Access to web-based communication, including video-teleconference
- Permanent address in the United States
Exclusion
- Not having such a diagnosis of EPM1-related disease.
Key Trial Info
Start Date :
October 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2030
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06593951
Start Date
October 10 2024
End Date
October 1 2030
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Childrens Hospital
Boston, Massachusetts, United States, 02115